2016 Hematological Malignancies

BV: Increased Pulmonary Toxicity Phase I Combination of BV and ABVD

ABVD with Brentuximab vedotin N=25

AVD with Brentuximab vedotin N=26

Preferred term

Any event

11 (44) 9 (36)

0 0 0 0

Pulmonary toxicity

Interstitial lung disease

1 (4) 1 (4)

Pneumonitis

Ansell S et al. presented at ASH 2012, San Diego, USA